巴塞爾醫學集團（BMGL）披露了購買價值超過10億美元的比特幣的計劃

巴塞爾醫療集團（BMGL）透露，它正在談論購買價值超過10億美元的比特幣。公司打算使用此資產

Basel Medical Group, Ltd (NASDAQ:BMGL) disclosed that it is in talks to purchase Bitcoin worth over $1 billion. The company intends to use this asset purchase to strengthen its treasury significantly compared to other Asia-focused healthcare firms. Management said the move would allow Basel Medical to accelerate its expansion strategy across high-growth Asian healthcare markets.

巴塞爾醫學集團有限公司（納斯達克股票代碼：BMGL）透露，正在談論購買價值超過10億美元的比特幣。與其他針對亞洲的醫療公司相比，該公司打算使用此資產購買來大大加強其財政部。管理層表示，此舉將使巴塞爾醫療在高增長的亞洲醫療保健市場中加速其擴張策略。

According to an official statement, Basel Medical Group is negotiating a deal with major investors to acquire Bitcoin through an innovative share-swap arrangement. The company’s CEO, Dr. Darren Chhoa, stated the initiative will provide unprecedented financial strength and flexibility. He emphasized that the transaction would position Basel Medical with one of the strongest balance sheets among healthcare providers focusing on Asia.

根據官方聲明，巴塞爾醫學集團正在與主要投資者進行協議，以通過創新的股票交易安排獲得比特幣。該公司的首席執行官達倫·喬亞（Darren Chhoa）博士表示，該計劃將提供前所未有的財務實力和靈活性。他強調，這項交易將把巴塞爾醫療的保證與關注亞洲的醫療保健提供者中最強大的資產負債表定位。

“We are also engaging in discussions with a few institutional investors and high-net-worth individuals to facilitate a seamless and mutually beneficial exchange of shares in Basel Medical Group for a sizable Bitcoin holding, valued at over $1 billion, in the aggregate, ” said Dr. Chhoa. “This transaction is pending the approval of our shareholders and relevant regulatory authorities.”

“我們還正在與一些機構投資者和高淨值個人進行討論，以促進巴塞爾醫療集團中股份的無縫和互惠互利的交換，以大量的比特幣持有，價值超過10億美元，總計超過10億美元，” Chhoa博士說。 “這項交易是在我們的股東和相關監管機構的批准之前。”

The company expects this capital administration to enhance its ability to participate in future mergers and acquisitions. The firm anticipates that a treasury backed by Bitcoin will assist in building strong financial foundations and reducing market volatility risks. The company aims to finalize transaction terms by the end of this quarter, following approval from regulatory authorities and the firm’s shareholders.

該公司預計該資本管理將增強其參與未來併購的能力。該公司預計，由比特幣支持的財政部將有助於建立強大的財務基礎並降低市場波動風險。在監管機構和公司的股東批准之後，該公司旨在在本季度末完成交易條款。

The announcement sparked an immediate sell-off in the stock market, which caused Basel Medical Group’s shares to tumble by over 9%. The drop in Basel Medical shares indicates investors’ cautious approach to businesses that invest in Bitcoin. Similarly, GameStop (NYSE:GME) saw its market capitalization fall by over $3 billion in March when it revealed its strategy to invest in Bitcoin.

該公告引發了股票市場的立即拋售，這導致巴塞爾醫療集團的股票下跌9％以上。巴塞爾醫療股份的下跌表明投資者對投資比特幣的企業的謹慎方法。同樣，GameStop（NYSE：GME）在3月透露其投資比特幣的策略時，其市值下降了30億美元。

Basel Medical’s move aligns it with other public firms, including Japan’s Metaplanet and Semler Scientific (NASDAQ:SEML), which have adopted Bitcoin as part of their treasury strategies. MicroStrategy (NASDAQ:MCRI) pioneered this approach and now holds nearly 569,000 Bitcoins, becoming a leader among corporate Bitcoin holders. Corporate treasuries worldwide now control about $80 billion in Bitcoin, according to BitcoinTreasuries.net.

巴塞爾醫療的舉動與其他公共公司（包括日本的Metaplanet和Semler Scientific（NASDAQ：SEML））保持一致，這些公司已將比特幣作為其國庫策略的一部分。 MicroStrategy（NASDAQ：MCRI）開創了這種方法，現在擁有將近569,000個比特幣，成為公司比特幣持有人的領導者。根據BitCoinReasuries.net的數據，全球公司國庫現在控制了大約800億美元的比特幣。

Basel Medical Group, which specializes in orthopedic and trauma services, sees the Bitcoin acquisition as a step toward building a premier healthcare platform in Southeast Asia. The group recently acquired Bethesda Medical, marking the beginning of its regional expansion strategy.

專門從事骨科和創傷服務的巴塞爾醫學集團將比特幣的收購視為在東南亞建立主要的醫療平台的一步。該組織最近收購了貝塞斯達醫療，標誌著其區域擴張策略的開始。

Management expects the strengthened balance sheet to enable quick responses to strategic opportunities in Asia’s rapidly growing healthcare sector. According to Dr Chhoa, the purchase will enable Basel Medical Group to become more flexible and resilient in expanding into new markets and business sectors.

管理層預計，加強的資產負債表可以在亞洲快速發展的醫療保健領域中快速回應戰略機會。根據Chhoa博士的說法，此次購買將使巴塞爾醫學集團在擴展到新市場和業務部門方面變得更加靈活和韌性。